These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 24137216)

  • 1. Influence of infection on the distribution patterns of NIH-Chronic Prostatitis Symptom Index scores in patients with chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS).
    Magri V; Wagenlehner FM; Marras E; VAN Till JW; Houbiers J; Panagopoulos P; Petrikkos GL; Perletti G
    Exp Ther Med; 2013 Aug; 6(2):503-508. PubMed ID: 24137216
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multimodal therapy for category III chronic prostatitis/chronic pelvic pain syndrome in UPOINTS phenotyped patients.
    Magri V; Marras E; Restelli A; Wagenlehner FM; Perletti G
    Exp Ther Med; 2015 Mar; 9(3):658-666. PubMed ID: 25667610
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multidisciplinary approach to prostatitis.
    Magri V; Boltri M; Cai T; Colombo R; Cuzzocrea S; De Visschere P; Giuberti R; Granatieri CM; Latino MA; Larganà G; Leli C; Maierna G; Marchese V; Massa E; Matteelli A; Montanari E; Morgia G; Naber KG; Papadouli V; Perletti G; Rekleiti N; Russo GI; Sensini A; Stamatiou K; Trinchieri A; Wagenlehner FME
    Arch Ital Urol Androl; 2019 Jan; 90(4):227-248. PubMed ID: 30655633
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical utility of the UPOINT phenotype system in Chinese males with chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS): a prospective study.
    Zhao Z; Zhang J; He J; Zeng G
    PLoS One; 2013; 8(1):e52044. PubMed ID: 23349680
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distribution of the positive UPOINT domain in patients with chronic prostatitis or chronic pelvic pain syndrome: A multicenter observational study.
    Ichihara K; Takahashi S; Hiyama Y; Masumori N; Nagae H; Ito S; Wada K; Betsunoh H; Hamasuna R; Togo Y; Shigemura K; Takeyama K
    J Infect Chemother; 2022 May; 28(5):631-634. PubMed ID: 35101387
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of influence of the UPOINT-guided multimodal therapy in men with chronic prostatitis/chronic pelvic pain syndrome on dynamic values NIH-CPSI: a prospective, controlled, comparative study.
    Krakhotkin DV; Chernylovskyi VA; Bakurov EE; Sperl J
    Ther Adv Urol; 2019; 11():1756287219857271. PubMed ID: 31263510
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Erectile Dysfunction in Chronic Prostatitis/Chronic Pelvic Pain Syndrome: Outcomes from a Multi-Center Study and Risk Factor Analysis in a Single Center.
    Zhang Y; Zheng T; Tu X; Chen X; Wang Z; Chen S; Yang Q; Wan Z; Han D; Xiao H; Sun X; Deng C
    PLoS One; 2016; 11(4):e0153054. PubMed ID: 27120096
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of the UPOINT phenotype system in treating Chinese patients with chronic prostatitis/chronic pelvic pain syndrome: a prospective study.
    Guan X; Zhao C; Ou ZY; Wang L; Zeng F; Qi L; Tang ZY; Dun JG; Liu LF
    Asian J Androl; 2015; 17(1):120-3. PubMed ID: 25248659
    [TBL] [Abstract][Full Text] [Related]  

  • 9. National Institutes of Health Chronic Prostatitis Symptom Index (NIH-CPSI) symptom evaluation in multinational cohorts of patients with chronic prostatitis/chronic pelvic pain syndrome.
    Wagenlehner FM; van Till JW; Magri V; Perletti G; Houbiers JG; Weidner W; Nickel JC
    Eur Urol; 2013 May; 63(5):953-9. PubMed ID: 23141933
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The evolving clinical picture of chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS): A look at 1310 patients over 16 years.
    Doiron RC; Tripp DA; Tolls V; Nickel JC
    Can Urol Assoc J; 2018 Jun; 12(6):196-202. PubMed ID: 29485036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An online UPOINT tool for phenotyping patients with chronic prostatitis.
    Tran CN; Li J; Shoskes DA
    Can J Urol; 2014 Apr; 21(2):7195-200. PubMed ID: 24775571
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of chronic prostatitis-like symptoms on the quality of life in a large group of men.
    Walz J; Perrotte P; Hutterer G; Suardi N; Jeldres C; Bénard F; Valiquette L; Karakiewicz PI
    BJU Int; 2007 Dec; 100(6):1307-11. PubMed ID: 17941922
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Two-year experience with the german-translated version of the NIH-CPSI in patients with CP/CPPS.
    Schneider H; Brähler E; Ludwig M; Hochreiter W; Collins MF; Eremenco S; Weidner W
    Urology; 2004 Jun; 63(6):1027-30. PubMed ID: 15183940
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic Pelvic Pain Syndrome in a Rural Area: Are We Paying Attention?
    Akhtar OS
    Cureus; 2021 Feb; 13(2):e13525. PubMed ID: 33786232
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of cernitin pollen extract vs tadalafil therapy for refractory chronic prostatitis/chronic pelvic pain syndrome: A randomized, prospective study.
    Matsukawa Y; Naito Y; Funahashi Y; Ishida S; Fujita T; Tochigi K; Kato M; Gotoh M
    Neurourol Urodyn; 2020 Sep; 39(7):1994-2002. PubMed ID: 32648985
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A prospective study on association of prostatic calcifications with sexual dysfunction in men with chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS).
    Zhao Z; Xuan X; Zhang J; He J; Zeng G
    J Sex Med; 2014 Oct; 11(10):2528-36. PubMed ID: 24735240
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of psychological stress, cortisol awakening response, and heart rate variability in patients with chronic prostatitis/chronic pelvic pain syndrome complicated by lower urinary tract symptoms and erectile dysfunction.
    Bai J; Gu L; Chen Y; Liu X; Yang J; Li M; Dong X; Yang S; Huang B; Wang T; Jin L; Liu J; Wang S
    Front Psychol; 2022; 13():903250. PubMed ID: 36405196
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Correlation between the phenotypic domains of the UPOINT system and sexual dysfunction in men with chronic prostatitis/chronic pelvic pain syndrome].
    Xu GS; Peng DW; Gao JJ; Zhang XS
    Zhonghua Nan Ke Xue; 2019 Jun; 25(6):496-499. PubMed ID: 32223082
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of a modification of the UPOINT clinical phenotype system for the chronic pelvic pain syndrome.
    Hedelin HH
    Scand J Urol Nephrol; 2009; 43(5):373-6. PubMed ID: 19921982
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clustering of UPOINT domains and subdomains in men with chronic prostatitis/chronic pelvic pain syndrome and contribution to symptom severity.
    Samplaski MK; Li J; Shoskes DA
    J Urol; 2012 Nov; 188(5):1788-93. PubMed ID: 22998916
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.